• No results found

[PDF] Top 20 Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

Has 10000 "Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema" found on our website. Below are the top 20 most common "Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema".

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema

... IVTA plus laser treatments received should be viewed positively in light of the number of patients ana- ...The need for retreatment was not a prospectively defined outcome and the reasons for ... See full document

6

COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDYAli Kasiri, Fereydoun Farrahi, Mostafa Feghhi, Behnam Sadeghi, Hesam Hedayati, Seyed Ahmad Rasoulinejad DOW

COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDYAli Kasiri, Fereydoun Farrahi, Mostafa Feghhi, Behnam Sadeghi, Hesam Hedayati, Seyed Ahmad Rasoulinejad DOWNLOAD/VIEW

... Intravitreal triamcinolone acetonide has been seen to be effective treatment adjuvant in number of ...diffuse macular edema after IVT ...undergoing laser treatment had better VA ... See full document

9

Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant

Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant

... with laser photocoagulation 1 month later, and retreatment with the DEX implant was done at 6 and 9 months as ...The laser photocoagula- tion was repeated at 3 month intervals as ...implant ... See full document

12

Treatment Options of Macular Edema Secondary to Retinal Vein Occlusion (RVO): A Review

Treatment Options of Macular Edema Secondary to Retinal Vein Occlusion (RVO): A Review

... 1) Triamcinolone Acetonide: is intermediate acting powerful ...of triamcinolone acetonide vs observation for 12 months [30] ...of triamcinolone versus focal laser showed that all groups ... See full document

14

Focal Laser Photocoagulation in Non-Center Involved Diabetic Macular Edema

Focal Laser Photocoagulation in Non-Center Involved Diabetic Macular Edema

... non-proliferative diabetic retinopathy secondary to type II diabetes mellitus were included in this ...a central subfield thickness (CST) ≤250 microns and ≥300 microns in at least one of the four ... See full document

8

Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: Series of cases

Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: Series of cases

... vitreous macular attachment, the macular edema is persistent because those metabolic agents remain in contact with the ...that macular edema lasted longer in eyes with vitreous ... See full document

5

Effect on untreated diabetic macular edema: posterior sub tenon triamcinolone versus intravitreal bevacizumab

Effect on untreated diabetic macular edema: posterior sub tenon triamcinolone versus intravitreal bevacizumab

... thus macular edema. Severity of macular edema is correlated with the level of VEGF in vitreous in DME patients [15,16] ...of macular edema [17] ...of Intravitreal ... See full document

5

Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema

Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema

... of macular edema with loss of visual acuity whereas six months after SBT injection retinal thickness and visual acuity remained ...follow-up. Macular edema is the main cause of loss of ... See full document

7

Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology

Comparison of the efficacy of intravitreal triamcinolone acetonide for cystoid macular edema with versus without serous retinal detachment in branch retinal vein occlusion: influence on macular sensitivity and morphology

... of macular thickness within the 10° and 20° fields of the occluded region between the SRD (−) group and the SRD (+) group, while there were no significant differences between the two groups with regard to ... See full document

10

Treatments for macular oedema following central retinal vein occlusion : systematic review

Treatments for macular oedema following central retinal vein occlusion : systematic review

... with macular oedema secondary to ...monthly intravitreal bevacizumab injections over 3 months (and afterwards as needed), and the intervention group also received 100 mg oral minocycline twice daily over 24 ... See full document

13

Intravitreal triamcinolone for intraocular inflammation and associated macular edema

Intravitreal triamcinolone for intraocular inflammation and associated macular edema

... Multifocal areas of infl ammation within the retina and choroid characterized by white dots are generally classifi ed as white dot syndromes. The white dot syndromes then can be organized into separate categories depending ... See full document

8

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion

... Laser photocoagulation therapy is considered unsafe if it is performed in the acute phase of ...the macular edema may worsen and cause retinal cell damage and permanent loss of ...grid ... See full document

6

Clinical study on the safety and efficacy of intravitreal triamcinolone for recalcitrant acular edema in south Indian population.

Clinical study on the safety and efficacy of intravitreal triamcinolone for recalcitrant acular edema in south Indian population.

... of intravitreal triamcinolone is appealing for a number of ...to diabetic macular edema is ...practice, laser treatment as advocated by the ETDRS xxviii remains the standard ... See full document

86

Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy

Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy

... The conclusions able to be drawn from this study are limited by the small sample size. While 45 patients were approached to participate, only nine were enrolled because of the time commitment on the day of injection and ... See full document

8

Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema

Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema

... and intravitreal injec- tion was performed as follows: for group I (IVT), ...mg) triamcinolone (Kenacort-A, SmithKline Beecham, an affiliated company to GalaxoSmithKline, London, UK) was injected in the ... See full document

6

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex<sup>®</sup>) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex<sup>&reg;</sup>) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion

... They inserted 0.7 mg DEX implants into both eyes of 34 male monkeys (Macaca fascicularis) and collected blood, vitreous humor, and retina samples at days 7, 30, 60, 90, 120, 150, 180, 210, 240, and 270 after ... See full document

7

Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice

Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice

... AGA has collected data from one of the three centers (Avicenne hospital) and has been involved in drafting the manuscript and revising it critically for important intellectual content. RT has collected data from one of ... See full document

6

Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion

Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion

... in macular sensitivity and macular thickness after intravitreal injection of triamcinolone acetonide (IVTA) in two patients with macular edema and central retinal ... See full document

6

Intravitreal Bevacizumab Injection versus Intravitreal Bevacizumab Injection Followed by Macular Grid Laser Photocoagulation for Diabetic Macular Edema

Intravitreal Bevacizumab Injection versus Intravitreal Bevacizumab Injection Followed by Macular Grid Laser Photocoagulation for Diabetic Macular Edema

... bilateral diabetic macular edema, randomly assigned into two ...monthly intravitreal bevacizumab injections (IVB ...by macular grid photocoagulation (MGP) 4 weeks later (combined ... See full document

10

Effects of sub-Tenon&amp;#39;s capsule triamcinolone acetonide injection combined with microa- neurysm photocoagulation on diabetic macular edema

Effects of sub-Tenon&#39;s capsule triamcinolone acetonide injection combined with microa- neurysm photocoagulation on diabetic macular edema

... The indications for MAPC were not specific, but the patients with MAs at the posterior pole underwent STTA combined with MAPC immediately or within 1 month after the STTA injection. Before MAPC, fluorescein angiography ... See full document

6

Show all 10000 documents...